From PERK to RIPK1: Design, synthesis and evaluation of novel potent and selective necroptosis inhibitors
Camilla Scarpellini(University of Antwerp), Koen Augustyns(University of Antwerp)
Cited by 3
Related Papers
Targeting ferroptosis protects against experimental (multi)organ dysfunction and death
|Nature Communications|2022|176
Ferroptosis contributes to multiple sclerosis and its pharmacological targeting suppresses experimental disease progression
|Cell Death and Differentiation|2023|93
Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver disease
|Cell Death and Differentiation|2024|36
Oxazole-Based Ferroptosis Inhibitors with Promising Properties to Treat Central Nervous System Diseases
|Journal of Medicinal Chemistry|2025|12
Targeting ferroptosis protects against multiorgan dysfunction and death.
|Research Square|2021|1